|
|
Article: Cambridge Antibody Technology Announces New Chief Executive Officer.
- Article from:
- PR Newswire
- Article date:
- February 25, 2002
CopyrightCOPYRIGHT 2002 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Melbourn, U.K. -- Cambridge Antibody Technology is pleased to announce the appointment of Peter Chambre as the Company's new Chief Executive Officer (CEO) with effect from early April. He will join the CAT Board at that time.
Peter Chambre was Chief Operating Officer at Celera Genomics Group until November 2001. Previously he held the post of CEO at Bespak PLC, a global supplier of drug delivery technology and delivery systems in the field of inhaled therapies. He has also held positions at Bain & Company, Unilever PLC and others.
Peter Garland, CAT's Chairman, commented "We are delighted that Peter has agreed to join CAT at this time when the Company ...